Filter
890
Text search:
adverse
drug
reactions
Featured
Recommendations
116
New Publications
260
Language
Document type
No document type
585
Guidelines
144
Studies & Reports
79
Manuals
42
Strategic & Response Plan
13
Fact sheets
11
Training Material
9
Situation Updates
3
Brochures
2
Resource Platforms
1
Infographics
1
Countries / Regions
India
68
Kenya
28
South Africa
27
Ethiopia
26
Tanzania
22
Western and Central Europe
21
Uganda
19
Nigeria
17
Zambia
17
Global
17
Malawi
16
Nepal
15
Ghana
14
Philippines
10
Cambodia
10
Bangladesh
10
Latin America and the Carribbean
10
Eastern Europe
10
Sierra Leone
9
Zimbabwe
9
Liberia
8
Namibia
8
Myanmar / Burma
8
Africa
8
USA
6
Rwanda
6
Botswana
6
Eswatini/ Swaziland
5
South–East Asia Region
5
South Sudan
3
Germany
3
Syria
3
Indonesia
3
Brazil
3
Ukraine
3
Western Pacific Region
3
Congo, Democratic Republic of
2
Haiti
2
Thailand
2
Argentina
2
Colombia
2
Bolivia
2
Lesotho
2
Sri Lanka
2
Asia
2
Timor Leste/ East Timor
2
Russia
2
Cameroon
1
Iraq
1
Lebanon
1
Gambia
1
China
1
Ireland
1
Mozambique
1
Benin
1
Angola
1
West and Central Africa
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Fiji
1
Solomon Islands
1
Bhutan
1
North Korea
1
Laos
1
Australia
1
Georgia
1
Vietnam
1
North America
1
Authors & Publishers
Publication Years
Category
Countries
351
Clinical Guidelines
136
Public Health
43
Women & Child Health
26
Capacity Building
15
Key Resources
12
Pharmacy & Technologies
11
Toolboxes
TB
130
Mental Health
78
HIV
69
Pharmacy
66
COVID-19
35
NTDs
34
AMR
27
Ebola
18
Caregiver
17
NCDs
14
Rapid Response
12
Refugee
10
Polio
8
Conflict
8
Specific Hazards
5
Cholera
4
Natural Hazards
4
Planetary Health
4
Disability
3
Zika
3
Global Health Education
3
Health Financing Toolbox
1
Revised Edition
Guidelines for treatment of drug-susceptible tuberculosisand patient care
2017 Update
Mental Health First Aid Guidelines
Accessed: 14.03.2019
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported
...
The publication of the Second Edition of the Emergency Drug Guidelines represents the culmination of the efforts of the National Drugs and Therapeutics Committee (NDTC) to publish clinical drug guid
...
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initi
...
Emergence of antimicrobial resistance is a result of the use, overuse and misuse of antibiotics both in humans and animals. In Ethiopia, there are indications on the misuse of antibiotics by health care providers’, unskilled practitioners, and drug
...
Guidelines for treatment of drug-susceptible tuberculosis and patient care
2017 update
N Engl J Med 2022; 386:911-922, DOI: 10.1056/NEJMoa2104535
Four months of antituberculosis treatment was noninferior to 6 months of treatment in children with drug-susceptible, nonsevere, smear-negative tuberculosis (SHINE Study)
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resis
...
Q8. Should Anti-Epileptic Drug (AED) treatment be started after first unprovoked seizure in non-specialist health settings?
Q12: Should the treatment be similar in individuals with intellectual disability and epilepsy compared to people with epilepsy only?
Document No. : FDA/SMC/SMD/GL-SMP/2015/05 |
These guidelines are for information, guidance and strict compliance by Marketing Authorization Holders and Local Representatives of regulated products to help in the continuous safety monitoring of products granted marketing authorization in Ghana.
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.